Pathway Financial Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.18M | Buy |
4,500
+1,100
| +32% | +$256K | 0.14% | 64 |
|
|
2026
Q1 | $826K | Sell |
3,400
-1,573
| -32% | -$366K | 0.1% | 66 |
|
|
2025
Q4 | $1.02M | Hold |
4,973
| – | – | 0.13% | 65 |
|
|
2025
Q3 | $922K | Hold |
4,973
| – | – | 0.12% | 67 |
|
|
2025
Q2 | $760K | Sell |
4,973
-66
| -1% | -$10.1K | 0.11% | 68 |
|
|
2025
Q1 | $836K | Sell |
5,039
-10
| -0.2% | -$1.56K | 0.15% | 66 |
|
|
2024
Q4 | $730K | Buy |
5,049
+74
| +1% | +$11.5K | 0.17% | 69 |
|
|
2024
Q3 | $806K | Sell |
4,975
-561
| -10% | -$89.4K | 0.21% | 57 |
|
|
2024
Q2 | $809K | Hold |
5,536
| – | – | 0.22% | 57 |
|
|
2024
Q1 | $876K | Buy |
5,536
+98
| +2% | +$15.6K | 0.24% | 51 |
|
|
2023
Q4 | $852K | Buy |
5,438
+226
| +4% | +$34.7K | 0.25% | 49 |
|
|
2023
Q3 | $812K | Sell |
5,212
-111
| -2% | -$18.3K | 0.28% | 44 |
|
|
2023
Q2 | $881K | Buy |
5,323
+2
| +0% | +$323 | 0.29% | 40 |
|
|
2023
Q1 | $825K | Hold |
5,321
| – | – | 0.28% | 40 |
|
|
2022
Q4 | $940K | Sell |
5,321
-1,208
| -19% | -$209K | 0.29% | 39 |
|
|
2022
Q3 | $1.07M | Buy |
6,529
+886
| +16% | +$150K | 0.37% | 36 |
|
|
2022
Q2 | $1M | Buy |
5,643
+55
| +1% | +$9.8K | 0.42% | 38 |
|
|
2022
Q1 | $990K | Sell |
5,588
-84
| -1% | -$14.3K | 0.37% | 39 |
|
|
2021
Q4 | $977K | Buy |
+5,672
| New | +$929K | 0.35% | 38 |
|
|
2021
Q1 | $950K | Hold |
5,555
| – | – | 0.38% | 36 |
|
|
2020
Q4 | $880K | Sell |
5,555
-13
| -0.2% | -$1.92K | 0.37% | 37 |
|
|
2020
Q3 | $820K | Sell |
5,568
-247
| -4% | -$36.5K | 0.32% | 34 |
|
|
2020
Q2 | $818K | Sell |
5,815
-1,352
| -19% | -$197K | 0.25% | 35 |
|
|
2020
Q1 | $962K | Buy |
7,167
+1,427
| +25% | +$202K | 0.32% | 27 |
|
|
2019
Q4 | $857K | Buy |
5,740
+3,131
| +120% | +$425K | 0.24% | 41 |
|
|
2019
Q3 | $347K | Sell |
2,609
-15
| -0.6% | -$1.98K | 0.1% | 66 |
|
|
2019
Q2 | $366K | Sell |
2,624
-326
| -11% | -$45.1K | 0.11% | 64 |
|
|
2019
Q1 | $412K | Buy |
2,950
+458
| +18% | +$61.3K | 0.13% | 59 |
|
|
2018
Q4 | $322K | Hold |
2,492
| – | – | 0.18% | 67 |
|
|
2018
Q3 | $324K | Sell |
2,492
-11,029
| -82% | -$1.47M | 0.18% | 68 |
|
|
2018
Q2 | $1.64M | Hold |
13,521
| – | – | 0.96% | 19 |
|
|
2018
Q1 | $1.73M | Sell |
13,521
-26
| -0.2% | -$3.51K | 1.01% | 18 |
|
|
2017
Q4 | $1.89M | Buy |
+13,547
| New | +$1.89M | 1.09% | 17 |
|
Other funds holding JNJ
Pathway Financial Advisors's JNJ Position: Q2 2026 in Review
Pathway Financial Advisors increased its Johnson & Johnson (JNJ) stake by 32% in Q2 2026, buying an estimated $256K and bringing the position to 4,500 shares worth $1.18M. The position accounts for 0.14% of the portfolio, ranked #64.
Pathway Financial Advisors first reported a position in JNJ in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.89M in Q4 2017. 4,676 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Pathway Financial Advisors held 4,500 shares of Johnson & Johnson worth $1.18M as of Q2 2026.
- Pathway Financial Advisors bought 1,100 Johnson & Johnson shares in Q2 2026, an estimated $256K.
- Johnson & Johnson made up 0.14% of Pathway Financial Advisors's portfolio in Q2 2026, its #64 holding.
- Pathway Financial Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 33 quarters since.
- Pathway Financial Advisors's Johnson & Johnson position peaked at $1.89M in Q4 2017.
- 4,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Pathway Financial Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.